Related Experiment Videos

A new era in atherosclerosis drug discovery

Expert Review of Cardiovascular Therapy

|September 8, 2004

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Carboxylated, heteroaryl-substituted chalcones as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.

Journal of medicinal chemistry·2007

Atherosclerosis is an inflammatory disorder after all.

Current topics in medicinal chemistry·2006

AGIX-4207 [2-[4-[[1-[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]thio]-1-methylethyl]thio]-2,6-bis(1,1-dimethylethyl)phenoxy]acetic acid], a novel antioxidant and anti-inflammatory compound: cellular and biochemical characterization of antioxidant activity and inhibition of redox-sensitive inflammatory gene expression.

The Journal of pharmacology and experimental therapeutics·2005

Inflammation in atherosclerosis: new opportunities for drug discovery.

Mini reviews in medicinal chemistry·2005

Discovery of novel phenolic antioxidants as inhibitors of vascular cell adhesion molecule-1 expression for use in chronic inflammatory diseases.

Journal of medicinal chemistry·2004

Discovery of novel heteroaryl-substituted chalcones as inhibitors of TNF-alpha-induced VCAM-1 expression.

Bioorganic & medicinal chemistry letters·2004

See all related articles